With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

What happens if you stop GLP-1 weight loss injections like semaglutide and tirzepatide? Dr Bernard Tan from Bay Medical ...

There are growing concerns about the side effects caused by weight loss injections such as Ozempic, Wegovy and Mounjaro.

Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who ...

However, if you're planning to ask your GP to prescribe it, are you actually eligible and do you meet the very specific ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.